Robust and tissue-independent gender-specific transcript biomarkers

Biomarkers

Volumn 18, Issue 5, 2013, Pages 436-445

  Staedtler, Frank ^a,b   Hartmann, Nicole ^a,b   Letzkus, Martin ^a,b   Bongiovanni, Sandrine ^a,b   Scherer, Andreas ^c   Marc, Philippe ^a   Johnson, Keith J ^a,b   Schumacher, Martin M ^a,b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c Spheromics ^*  (Finland)

Author keywords

Gender; Prediction; Quality control; Transcriptome

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BLOOD; CONTROLLED STUDY; DDX3Y; EIF1AY GENE; FEMALE; GENE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; KDM5D GENE; MALE; MICROARRAY ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RPS4Y1 GENE; SEX DETERMINATION; XIST GENE;

BIOLOGICAL MARKERS; DEAD-BOX RNA HELICASES; FEMALE; GENE EXPRESSION PROFILING; HISTONE DEMETHYLASES; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SPECIFICITY; RIBOSOMAL PROTEINS; RNA, LONG NONCODING; RNA, MESSENGER; SEX DETERMINATION ANALYSIS; TRANSCRIPTOME;

EID: 84880540860     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2013.811538     Document Type: Article

References (38)

1. Benoit MH, Hudson TJ, Maire G, et al. (2007). Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines. Int J Oncol 30:5-17.
2. Brockdorff N. (2011). Chromosome silencing mechanisms in X-chromosome inactivation: unknown unknowns. Development 138: 5057-65.
3. Carrel L, Willard HF. (2005). X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434:400-4.
4. Chomczynski P, Sacchi N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt Biochem 162:156-9.
5. Eyre TA, Ducluzeau F, Sneddon TP, et al. (2006). The HUGO Gene Nomenclature Database, 2006 updates. Nucleic Acids Res 34: D319-21.
6. Fiegler H, Redon R, Andrews D, et al. (2006). Accurate and reliable high-throughput detection of copy number variation in the human genome. Genome Res 16:1566-74.
7. Fisher EM, Beer-Romero P, Brown LG, et al. (1990). Homologous ribosomal protein genes on the human X and Y chromosomes: escape from X inactivation and possible implications for Turner syndrome. Cell 63:1205-18.
8. Foresta C, Ferlin A, Moro E. (2000). Deletion and expression analysis of AZFa genes on the human Y chromosome revealed a major role for DBY in male infertility. Hum Mol Genet 9:1161-9.
9. Galfalvy HC, Erraji-Benchekroun L, Smyrniotopoulos P, et al. (2003). Sex genes for genomic analysis in human brain: internal controls for comparison of probe level data extraction. BMC Bioinformatics 4:37.
10. Goldberg SI, Niemierko A, Turchin A. (2008). Analysis of data errors in clinical research databases. AMIA Annual Symp Proc 6:242-6.
11. Goodsaid F. (2012). Challenges of biomarkers in drug discovery and development. Expert Opin Drug Discov 7:457-61.
12. Goodsaid F, Frueh F. (2006). Process map proposal for the validation of genomic biomarkers. Pharmacogenomics 7:773-82.
13. Hughes JF, Rozen S. (2012). Genomics and genetics of human and primate y chromosomes. Annu Rev Genomics Hum Genet 13:83-108.
14. Isensee J, Ruiz Noppinger P. (2007). Sexually dimorphic gene expression in mammalian somatic tissue. Gend Med 4:S75-95.
15. Jiang B, Tan AS, Chong SS. (2012). Molecular strategies for preimplantation genetic diagnosis of single gene and chromosomal disorders. Best Pract Res Clin Obstet Gynaecol 26:551-9.
16. Karchin R, Monteiro AN, Tavtigian SV, et al. (2007). Functional impact of missense variants in BRCA1 predicted by supervised learning. PLoS Comput Biol 3:e26.
17. Karyagyna AS, Vassiliev MO, Ershova AS, et al. (2010). Probe-Level Universal Search (PLUS) algorithm for gender differentiation in affymetrix datasets. J Bioinform Comput Biol 8:553-77.
18. Lahn BT, Page DC. (1997). Functional coherence of the human Y chromosome. Science 278:675-80.
19. Lockhart DJ, Dong H, Byrne MC, et al. (1996). Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14:1675-80.
20. MacKay DJC. (2002). Information theory, inference & learning algorithms. New York: Cambridge University Press. ISBN-10: 0521642981.
21. Marrer E, Dieterle F. (2007). Promises of biomarkers in drug development - a reality check. Chem Biol Drug Des 69:381-94.
22. May KO. (1952). A set of independent necessary and sufficient conditions for simple majority decision. Econometrica 20:680-4.
23. Paulsen M. (2011). Unique patterns of evolutionary conservation of imprinted genes. Clin Epigenetics 2:405-10.
24. Penrose LS. (1946). The elementary statistics of majority voting. J R Stat Soc 109:53-7.
25. Plath K, Mlynarczyk-Evans S, Nusinow DA, Panning B. (2002). Xist RNA and the mechanism of X chromosome inactivation. Ann Rev Genet 36:233-78.
26. Quackenbush J. (2002). Microarray data normalization and transformation. Nat Genet 32:496-501.
27. Reynolds R, Varlaro J. (1996). Gender determination of forensic samples using PCR amplification of ZFX/ZFY gene sequences. J Forensic Sci 41:279-86.
28. Sirchia SM, Ramoscelli L, Grati FR, et al. (2005). Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells. Cancer Res 65:2139-46.
29. Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, et al. (2003). The malespecific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 423:825-37.
30. Talebizadeh Z, Simon SD, Butler MG. (2006). X chromosome gene expression in human tissues: male and female comparisons. Genomics 88:675-81.
31. Tang Y, Lu A, Ran R, et al. (2004). Human blood genomics: distinct profiles for gender, age and neurofibromatosis type 1. Brain Res Mol Brain 132:155-67.
32. Tattermusch A, Brockdorff N. (2011). A scaffold for X chromosome inactivation. Hum Genet 130:247-53.
33. US Food and Drug Administration. (2005). Guidance for industry pharmacogenomic data submissions. Available at: http://www.fda. gov/downloads/RegulatoryInformation/Guidances/ucm126957.pdf [last accessed 28 May 2013].
34. US Food and Drug Administration. Table of valid genomic biomarkers in the context of approved drug labels. Available at: http:// www.fda.gov/cder/ genomics/genomic-biomarkers-table.htm [last accessed 28 May 2013].
35. Vawter MP, Evans S, Choudary P, et al. (2004). Gender-specific gene expression in post-mortem human brain: localization to sex chromosomes. Neuropsychopharmacology 29: 373-84.
36. Williams PM, Lively TG, Jessup JM, Conley BA. (2012). Bridging the gap: moving predictive and prognostic assays from research to clinical use. Clin Cancer Res 18:1531-9.
37. Williams SA, Slavin DE, Wagner JA, Webster CJ. (2006). A costeffectiveness approach to the qualification and acceptance of biomarkers. Nat Rev Drug Discov 5:897-902.
38. Wit E, McClure J. (2004). Statistics for microarrays. Design, analysis and inference. West Sussex, UK: John Wiley & Sons. ISBN-10: 0470849932.